Henry Schein Q2 EPS Estimate Decreased by Leerink Partnrs

Henry Schein, Inc. (NASDAQ:HSIC) – Stock analysts at Leerink Partnrs reduced their Q2 2025 earnings per share (EPS) estimates for shares of Henry Schein in a report issued on Tuesday, February 25th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $1.23 per share for the quarter, down from their prior forecast of $1.24. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein’s Q4 2025 earnings at $1.29 EPS, FY2025 earnings at $4.92 EPS, FY2026 earnings at $5.48 EPS and FY2027 earnings at $6.05 EPS.

Other equities research analysts have also issued research reports about the company. Barrington Research restated an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a research report on Wednesday. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Mizuho began coverage on Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target on the stock. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and increased their price target for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Finally, UBS Group cut their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Trading Down 4.3 %

Shares of HSIC stock opened at $72.54 on Thursday. The stock has a market cap of $9.04 billion, a price-to-earnings ratio of 29.85, a PEG ratio of 2.13 and a beta of 0.91. The stock has a 50-day moving average of $74.28 and a 200-day moving average of $72.43. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein has a 1-year low of $63.67 and a 1-year high of $82.63.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.66 EPS.

Institutional Trading of Henry Schein

A number of institutional investors and hedge funds have recently modified their holdings of the business. Smartleaf Asset Management LLC increased its position in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after acquiring an additional 143 shares during the last quarter. Guggenheim Capital LLC increased its position in Henry Schein by 2.5% in the fourth quarter. Guggenheim Capital LLC now owns 6,428 shares of the company’s stock worth $445,000 after buying an additional 159 shares during the last quarter. CIBC Asset Management Inc increased its position in Henry Schein by 1.0% in the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock worth $1,235,000 after buying an additional 169 shares during the last quarter. Studio Investment Management LLC increased its position in Henry Schein by 3.8% in the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock worth $341,000 after buying an additional 172 shares during the last quarter. Finally, Metis Global Partners LLC increased its position in Henry Schein by 4.7% in the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company’s stock worth $291,000 after buying an additional 187 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.